Skip to Content
About Us Become an Authorised Buyer Medical Partners Blog Contact Us
🌐Ship toSelect country
  1. All products
  2. Fillers
  3. Brands
  4. Saypha Filler - 1 x 1,0ml
  5. Brands
Pricelist: Default Pricelist
Pricelist: Default Pricelist
Saypha Filler - 1 x 1,0ml

Saypha Filler - 1 x 1,0ml

Saypha Filler is a Croma-Pharma (Austria) hyaluronic acid dermal filler built on the brand's SMART (Supreme Monophasic And Reticular Technology) cross-linking process. It is indicated for correction of moderate to severe nasolabial folds, and also used for reconstructive purposes such as facial lipoatrophy, debilitating scars or morphological asymmetry, injected into the mid-to-deep dermis. Estimated duration in the skin is around 5 months. For use by licensed, trained medical professionals only.

Cross-Linked Hyaluronic Acid
46.00 € 46.00 €
  • Brand
Contact Us
Terms and Conditions

Shipping: 
DHL EXPRESS SHIPPING (EU) — approx. 2-3 working days
STANDARD SHIPPING (EU) — approx. 7-10 working days
Select your delivery country in the header to check availability for your destination.
Category Fillers Brand Saypha
SKU A4800 Share
Treatment Areas CheeksChinMarionette LinesNasolabial folds
Tags Cross-Linked Hyaluronic Acid

Saypha Filler is a cross-linked hyaluronic acid dermal filler from Croma-Pharma GmbH (Leobendorf, Austria), successor to the brand's earlier 'Princess' filler line. Formulated at 23mg/g with BDDE cross-linking, it corrects moderate facial wrinkles and lines and can enhance lip volume.

CONCENTRATION

  • Cross-linked hyaluronic acid 23mg/g (BDDE)

THE PACK INCLUDES

  • 1 x 1.0ml Syringe

STORAGE CONDITIONS

  • Store between 2°C and 25°C

RESULTS & DURATION

Results typically last 6-9 months, depending on individual metabolism.

INDICATIONS

  • Moderate facial wrinkles and folds
  • Lip enhancement

TREATMENT AREAS

  • Nasolabial folds
  • Lips
  • Face, general

Saypha Filler is injected into the mid to deep dermis using linear threading or fanning technique.

Results are visible immediately, with final results assessed after 2-4 weeks.

  • Pregnancy or breastfeeding
  • People under the age of 18
  • Active infection or inflammation at the treatment site
  • Known hypersensitivity to hyaluronic acid or lidocaine
  • Patients prone to hypertrophic scarring
  • Autoimmune diseases affecting the skin